The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Retinal vascular change or degeneration already has been associated with Alzheimer and Parkinson disease, and the findings ...

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...

For patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a study ...

A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema ... more Early Treatment of Diabetic Retinopathy Study (ETDRS) letters ...

What Is Diabetic Macular Edema (DME ... protective cells inside your blood vessels and weakens your vessel walls. When this happens in your eye, fluid can leak into your retina, causing swelling ...

UBX1325 is a novel BCL-xL inhibitor that is designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving healthy ones intact. UBX1325 is administered via intravitreal ...

and gene and cell therapies targeting multiple vision-threatening conditions, including retinal vascular and diabetic eye diseases, geographic atrophy, and autoimmune conditions, such as thyroid eye ...

About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema The DIAMOND ... OCS-05 has shown positive results in prevention of retinal ganglion cell damage and was associated with ...

Innovate Retina focuses exclusively on game-changing innovations in medical and surgical retina care, including current management of age-related macular degeneration (AMD) and diabetic retinopathy ..

But if you have macular edema, fluid collects in the retina and causes ... Type 1 and type 2 diabetes cause DME. Constant high blood sugar weakens connections between cells in small blood vessels ...